LNA 8-mer oligonucletides (Santaris)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameLNA 8-mer oligonucletides (Santaris)

Drug Alias NameLocked Nucleic Acid 8-mer oligonucleotides (Santaris)

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNASmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionAntisense oligonucleotide inhibitors

TargetsUpdating

Therapy Area/IndicationsCardiovascular DiseasesMuscular DiseasesNeoplasms +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesRoche Innovation Center Copenhagen A/S

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRoche Innovation Center Copenhagen A/S

Active IndicationsN/A

Inactive IndicationsCardiovascular DiseasesMuscular DiseasesNeoplasms +[4]

Other Information

ATC CodeN/A